News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
106,858 Results
Type
Article (4251)
Company Profile (19)
Press Release (102588)
Section
Business (31968)
Career Advice (109)
Deals (5248)
Drug Delivery (5)
Drug Development (5400)
Employer Resources (11)
FDA (3199)
Job Trends (2076)
News (46950)
Policy (3872)
Tag
Academia (363)
Alliances (11138)
Alzheimer's disease (297)
Approvals (3205)
Artificial intelligence (60)
Bankruptcy (46)
Best Places to Work (1718)
Breast cancer (45)
Cancer (297)
Cardiovascular disease (18)
Career advice (100)
Clinical research (4126)
Collaboration (127)
COVID-19 (476)
C-suite (22)
Data (159)
Diagnostics (5667)
Earnings (10298)
Events (13382)
Executive appointments (74)
FDA (3331)
Funding (101)
GLP-1 (36)
Government (623)
Healthcare (2903)
Infectious disease (494)
IPO (1786)
Job creations (401)
Job search strategy (95)
Layoffs (23)
Legal (531)
Lung cancer (31)
Lymphoma (21)
Manufacturing (35)
Medical device (2439)
Medtech (2439)
Mergers & acquisitions (3513)
Metabolic disorders (24)
Multiple sclerosis (13)
Neuroscience (338)
NextGen: Class of 2025 (703)
Non-profit (547)
Northern California (257)
Parkinson's disease (13)
People (8891)
Phase I (1253)
Phase II (1737)
Phase III (1577)
Pipeline (62)
Postmarket research (212)
Preclinical (588)
Prostate cancer (26)
Radiopharmaceuticals (119)
Rare diseases (23)
Real estate (859)
Regulatory (2966)
Research institute (425)
Resumes & cover letters (15)
Series A (13)
Southern California (211)
Startups (622)
United States (2336)
Vaccines (30)
Date
Today (25)
Last 7 days (121)
Last 30 days (390)
Last 365 days (5093)
2025 (378)
2024 (5118)
2023 (6128)
2022 (10210)
2021 (9620)
2020 (8993)
2019 (6150)
2018 (4856)
2017 (5400)
2016 (5394)
2015 (6109)
2014 (4629)
2013 (4128)
2012 (4434)
2011 (4629)
2010 (4079)
Location
Africa (130)
Arizona (50)
Asia (5297)
Australia (1228)
California (559)
Canada (221)
China (26)
Colorado (36)
Connecticut (50)
Europe (15023)
Florida (70)
Georgia (30)
Illinois (77)
Indiana (19)
Japan (15)
Maine (20)
Maryland (72)
Massachusetts (316)
Michigan (56)
Minnesota (66)
Missouri (16)
New Hampshire (17)
New Jersey (104)
New Mexico (17)
New York (221)
North Carolina (163)
Northern California (257)
Ohio (21)
Pennsylvania (65)
South America (153)
Southern California (211)
Tennessee (16)
Texas (119)
Utah (57)
Virginia (26)
Washington State (50)
Wisconsin (23)
106,858 Results for "memed diagnostics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MeMed Expands Advisory Board with Key Leaders to Advance Host-Response Diagnostics for Sepsis and AMR
January 9, 2025
·
3 min read
Business
Beckman Coulter and MeMed Extend Partnership Advancing Host Immune Response Diagnostics
Beckman Coulter Diagnostics, a global leader in clinical diagnostics, and MeMed, a leader in the emerging field of advanced host-response technologies, announced expansion of their host immune response diagnostics partnership.
May 7, 2024
·
5 min read
Press Releases
FDA Grants Breakthrough Device Designation to MeMed Severity Test for Patients with Suspected Sepsis
December 10, 2024
·
3 min read
Business
MeMed Bolsters Leadership Team With Appointment of Ori Hadomi as Chairman and Peter Scheu as President of MeMed US
MeMed announces the appointment of Mr. Ori Hadomi as Chairman of the Board of Directors and Mr. Peter Scheu, as President of MeMed US.
November 6, 2023
·
2 min read
Policy
MeMed awarded US BARDA contract to demonstrate clinical utility of the FDA-cleared MeMed BV® test for distinguishing bacterial from viral infections
MeMed is pleased to announce that it has been awarded a contract valued at $727,799 by the Division of Research, Innovation, and Ventures of the U.S. Department of Health and Human Services, Biomedical Advanced Research and Development Authority.
October 24, 2023
·
2 min read
FDA
MeMed: FDA Clears Pioneering MeMed BV Test Direct From Whole Blood Allowing Faster Time To Result And Broader Patient Access When Distinguishing Bacterial From Viral Infections
MeMed, a leader in the emerging field of advanced host response technologies, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for use of the MeMed BV® test on whole blood samples on the point-of-need MeMed Key® analyzer to help healthcare providers distinguish between bacterial and viral infections in 15 minutes.
July 19, 2023
·
2 min read
Business
Beckman Coulter and MeMed to Expand Access to Proven Host Immune Response Diagnostic Able to Distinguish Between Bacterial and Viral Infections
Beckman Coulter Diagnostics announced today a strategic partnership to jointly develop and commercialize the proven MeMed BV® test, a host immune response diagnostic that is able to distinguish between bacterial and viral infections for use on the Access Family of Immunoassay Analyzers.
January 31, 2023
·
5 min read
Partnered
Ending the Diagnostic Odyssey for Patients
Ending the diagnostic journey for patients, particularly those with rare diseases, improves patients’ quality of life while reducing costs to healthcare systems.
December 11, 2024
·
4 min read
·
BioSpace Insights
Press Releases
Co-Diagnostics, Inc. and CoSara Diagnostics to Inaugurate New Oligo Facility
December 11, 2024
·
4 min read
Genetown
Clinical data published in Clinical Microbiology and Infection support use of MeMed’s test in reducing antibiotic overuse in children
MeMed, a leader in the emerging field of advanced host-response technologies, today announces positive results from AutoPilot, a prospective, multicenter study, that evaluated performance of MeMed’s test in distinguishing between bacterial and viral infections.
December 1, 2021
·
4 min read
1 of 10,686
Next